162 related articles for article (PubMed ID: 1774450)
1. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol.
Aguilar Diosdado M; Escobar-Jimenez L; Fernandez Soto ML; Garcia Curiel A; Escobar-Jimenez F
J Endocrinol Invest; 1991 Sep; 14(8):663-8. PubMed ID: 1774450
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy.
Hamon P; Bovier-Lapierre M; Robert M; Peynaud D; Pugeat M; Orgiazzi J
J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960
[TBL] [Abstract][Full Text] [Related]
3. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
Dulgeroff AJ; Geffner ME; Koyal SN; Wong M; Hershman JM
J Clin Endocrinol Metab; 1992 Oct; 75(4):1071-5. PubMed ID: 1400873
[TBL] [Abstract][Full Text] [Related]
5. Effects of thyroid hormones (T4,T3), bromocriptine and Triac on inappropriate TSH hypersecretion.
Salmela PI; Wide L; Juustila H; Ruokonen A
Clin Endocrinol (Oxf); 1988 May; 28(5):497-507. PubMed ID: 3214942
[TBL] [Abstract][Full Text] [Related]
6. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
Anzai R; Adachi M; Sho N; Muroya K; Asakura Y; Onigata K
Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347
[TBL] [Abstract][Full Text] [Related]
7. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
Radetti G; Persani L; Molinaro G; Mannavola D; Cortelazzi D; Chatterjee VK; Beck-Peccoz P
Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
Gershengorn MC; Weintraub BD
J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of bromocriptine administration for selective pituitary resistance to thyroid hormone.
Ohzeki T; Hanaki K; Motozumi H; Ohtahara H; Ishitani N; Urashima H; Tsukuda T; Shiraki K; Sasaki S; Nakamura H
Horm Res; 1993; 39(5-6):229-34. PubMed ID: 8314208
[TBL] [Abstract][Full Text] [Related]
10. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
[TBL] [Abstract][Full Text] [Related]
11. 3,5,3'-Triiodothyroacetic acid minimizes the pituitary thyrotrophin secretion in patients on levo-thyroxine therapy after ablative therapy for differentiated thyroid carcinoma.
Mueller-Gaertner HW; Schneider C
Clin Endocrinol (Oxf); 1988 Apr; 28(4):345-51. PubMed ID: 3142712
[TBL] [Abstract][Full Text] [Related]
12. [Resistance to thyroid hormone and Hashimoto's thyroiditis].
Guerra-Argüero LM; Gutiérrez-Saucedo JA; Gómez-Coello A; Gállego-Suárez C; Vázquez Mellado-Septién A
Cir Cir; 2011; 79(5):453-7. PubMed ID: 22385766
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC).
Beck-Peccoz P; Piscitelli G; Cattaneo MG; Faglia G
J Endocrinol Invest; 1983 Jun; 6(3):217-23. PubMed ID: 6619530
[No Abstract] [Full Text] [Related]
14. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
[TBL] [Abstract][Full Text] [Related]
15. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).
Guran T; Turan S; Bircan R; Bereket A
J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587
[TBL] [Abstract][Full Text] [Related]
16. [Hyperthyroidism caused by inadequate TSH secretion].
Zass R; Steindor U; Wendel U
Monatsschr Kinderheilkd; 1993 Feb; 141(2):100-2. PubMed ID: 7681522
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of thyroid hormone resistance.
Asteria C; Rajanayagam O; Collingwood TN; Persani L; Romoli R; Mannavola D; Zamperini P; Buzi F; Ciralli F; Chatterjee VK; Beck-Peccoz P
J Clin Endocrinol Metab; 1999 Feb; 84(2):405-10. PubMed ID: 10022392
[TBL] [Abstract][Full Text] [Related]
18. TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.
Mechelany C; Schlumberger M; Challeton C; Comoy E; Parmentier C
Clin Endocrinol (Oxf); 1991 Aug; 35(2):123-8. PubMed ID: 1934526
[TBL] [Abstract][Full Text] [Related]
19. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
Darendeliler F; Baş F
J Pediatr Endocrinol Metab; 1997; 10(5):535-8. PubMed ID: 9401912
[No Abstract] [Full Text] [Related]
20. Peripheral resistance to thyroid hormone in a family: heterogeneity of clinical presentation.
Pagliara AS; Caplan RH; Gundersen CB; Wickus GG; Elston AC
J Pediatr; 1983 Aug; 103(2):228-32. PubMed ID: 6410033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
